Valerie C. D.
- Country
- France
- Department
- Service de MédecineGénomique des Maladies Rares
Research Overview
- Evaluation of Romosozumab Versus Bisphosphonates in Pediatric Osteogenesis Imperfecta: A Phase 3, Open-Label, Multicenter, Randomized Study
- Efficacy and Safety Evaluation of Setrusumab in Osteogenesis Imperfecta: A Randomized Phase 2/3 Study with Dose-Evaluation and Placebo-Controlled Phases
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Vosoritide in Pediatric Patients with Achondroplasia: A Phase 2 Open-Label Extension Study
Data & Insights
Has run more than one trial at 19 of 46 partner sites.
Specializations
Skeletal Growth Disorders
This investigator specializes in treating rare genetic conditions affecting bone growth and development, with particular focus on achondroplasia and related skeletal dysplasias.
- Growth disorder management
- Genetic skeletal conditions
- Pediatric bone development
The research focuses on innovative therapeutic approaches for improving growth outcomes in children with skeletal dysplasias.
Bone Disorders
The investigator demonstrates expertise in treating osteogenesis imperfecta, also known as brittle bone disease, exploring both conventional and novel therapeutic approaches.
- Bone strength enhancement
- Fracture prevention
- Skeletal integrity
Special attention is given to developing treatments that improve bone density and reduce fracture occurrence in pediatric patients.
Pediatric Therapeutics
The investigator's work encompasses various treatment modalities for children with hypochondroplasia and other growth-related conditions.
- Growth velocity enhancement
- Long-term safety monitoring
- Developmental outcomes
Research efforts concentrate on evaluating therapeutic interventions that address both primary conditions and associated complications in pediatric patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.